Invention Grant
- Patent Title: 2-(heterocyclylbenzyl)pyridazinone derivatives
- Patent Title (中): 2-（杂环基苄基）哒嗪酮衍生物
-
Application No.: US12377072Application Date: 2007-07-12
-
Publication No.: US08435981B2Publication Date: 2013-05-07
- Inventor: Dieter Dorsch , Oliver Schadt , Andree Blaukat , Frank Stieber
- Applicant: Dieter Dorsch , Oliver Schadt , Andree Blaukat , Frank Stieber
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
- Current Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102006037478 20060810
- International Application: PCT/EP2007/006186 WO 20070712
- International Announcement: WO2008/017361 WO 20080214
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/10 ; C07D403/06 ; C07D403/14 ; C07D243/08 ; A61K31/5355 ; A61K31/501 ; A61K31/551 ; A61P35/00 ; A61P9/10 ; A61P27/02 ; A61P29/00 ; A61P19/02 ; A61P7/02
Abstract:
Compounds of the formula (I) in which R1, R2, R3, R4 and R5 have the meanings indicated in claim 1 are inhibitors of tyrosine kinases, in particular of met kinase and can be employed inter alia for the treatment of tumors.
Public/Granted literature
- US20100261697A1 2-(HETEROCYCLYLBENZYL)PYRIDAZINONE DERIVATIVES Public/Granted day:2010-10-14
Information query
